Authors:
WALKER RE
SPOONER KM
KELLY G
MCCLOSKEY V
WOODY JN
FALLOON J
BASELER M
PISCITELLI SC
DAVEY RT
POLIS MA
KOVACS JA
MASUR H
LANE HC
Citation: Re. Walker et al., INHIBITION OF IMMUNOREACTIVE TUMOR-NECROSIS-FACTOR-ALPHA BY A CHIMERIC ANTIBODY IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, The Journal of infectious diseases, 174(1), 1996, pp. 63-68
Authors:
KOVACS JA
BECHTEL C
DAVEY RT
FALLOON J
POLIS MA
WALKER RE
METCALF JA
DAVEY V
PISCITELLI SC
BASELER M
DEWAR R
SALZMAN NP
MASUR H
LANE HC
Citation: Ja. Kovacs et al., COMBINATION THERAPY WITH DIDANOSINE AND INTERFERON-ALPHA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - RESULTS OF A PHASE I II TRIAL/, The Journal of infectious diseases, 173(4), 1996, pp. 840-848
Authors:
MASUR H
WHITCUP SM
CARTWRIGHT C
POLIS M
NUSSENBLATT R
Citation: H. Masur et al., ADVANCES IN THE MANAGEMENT OF AIDS-RELATED CYTOMEGALOVIRUS RETINITIS, Annals of internal medicine, 125(2), 1996, pp. 126-136
Citation: H. Masur et Jh. Shelhamer, OUTPATIENT MANAGEMENT OF HIV-RELATED PNEUMONIA - IN RESPONSE, Annals of internal medicine, 125(11), 1996, pp. 938-939
Authors:
SHELHAMER JH
GILL VJ
QUINN TC
CRAWFORD SW
KOVACS JA
MASUR H
OGNIBENE FP
Citation: Jh. Shelhamer et al., THE LABORATORY EVALUATION OF OPPORTUNISTIC PULMONARY INFECTIONS, Annals of internal medicine, 124(6), 1996, pp. 585-599
Citation: H. Masur et J. Shelhamer, EMPIRIC OUTPATIENT MANAGEMENT OF HIV-RELATED PNEUMONIA - ECONOMICAL OR UNWISE, Annals of internal medicine, 124(4), 1996, pp. 451-453
Authors:
KAPLAN JE
HU DJ
HOLMES KK
JAFFE HW
MASUR H
DECOCK KM
Citation: Je. Kaplan et al., PREVENTING OPPORTUNISTIC INFECTIONS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS - IMPLICATIONS FOR THE DEVELOPING-WORLD, The American journal of tropical medicine and hygiene, 55(1), 1996, pp. 1-11
Authors:
SCHAEFFER MH
KRANTZ DS
WICHMAN A
MASUR H
REED E
VINICKY JK
Citation: Mh. Schaeffer et al., THE IMPACT OF DISEASE SEVERITY ON THE INFORMED CONSENT PROCESS IN CLINICAL RESEARCH, The American journal of medicine, 100(3), 1996, pp. 261-268
Citation: Je. Kaplan et al., USPHS AND IDSA COLLABORATE ON GUIDELINES TO PREVENT OPPORTUNISTIC INFECTIONS IN HIV-INFECTED PERSONS, EMERGING INFECTIOUS DISEASES, 1(3), 1995, pp. 102-103
Authors:
KAPLAN JE
MASUR H
HOLMES KK
MCNEIL MM
SCHONBERGER LB
NAVIN TR
HANSON DL
GROSS PA
JAFFE HW
LANIER D
SCHRAM N
COOPER E
FREEDBERG KA
MAYER K
BLINKHORN R
ELLNER J
ANGULO F
BERKELMAN R
BREIMAN R
BRYAN R
BUEHLER J
CLADWELL B
CASTRO K
CHILDS JE
CHU S
CIESIELSKI C
DROTMAN DP
EDLIN B
ELLERBROCK T
FLEMING P
GEITER L
HAJJEH R
HANSON D
HOLMBERG S
HUGHES J
JAFFE H
JONES J
JURANEK D
KAPLAN JE
KELLER D
MARTONE W
MILLER B
NAVIN T
NESLUND V
OSTROFF S
PELLETT PE
PINNER R
REEF S
REEVES WC
REGNERY R
RICHARDS F
ROGERS M
SIMONDS RJ
SIMONE P
SMITH D
SOLOMON S
SPIEGEL R
STEWART J
SWERDLOW D
VERNON S
WARD J
NEAL J
SCHLECH W
WILFERT C
HORSBURGH R
MCGOWAN J
RIMLAND D
GOLDBERGER M
TRAPNELL CB
BARR D
TORRES G
STETLER H
GROSS P
ELSADAR W
COTTON D
GREAVES W
BARTLETT J
CHAISSON R
FEINBERG J
QUINN T
HORMAN J
MACDONALD K
WILSON M
SPERLING R
AVANDANO A
BAKER AC
KALICA A
KOVACS J
POLIS M
SCHNITTMAN S
NELSON C
PHAIR J
BENSON C
WOOD B
HUGHES W
LUFT B
HYSLOP N
WHITLEY R
AMPEL N
DREW WL
KOEHLER J
WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - INTRODUCTION/, Clinical infectious diseases, 21, 1995, pp. 1-11
Authors:
KAPLAN JE
MASUR H
HOLMES KK
WILFERT CM
SPERLING R
BAKER SA
TRAPNELL CB
FREEDBERG KA
COTTON D
POWDERLY WG
JAFFE HW
LANIER D
SCHRAM N
COOPER E
MAYER K
BLINKHORN R
ELLNER J
ANGULO J
BERKELMAN R
BREIMAN R
BRYAN R
BEUHLER J
CALDWELL B
CASTRO K
CHILDS JE
CHU S
CIESIELSKI C
DROTMAN DP
EDLIN B
ELLERBROCK T
FLEMING P
GEITER L
HAJJEH R
HANSON D
HOLMBERG S
HUGHES J
JAFFE H
JONES J
JURANEK D
KELLER D
MARTONE W
MCNEIL MM
MILLER B
NAVIN T
NESLUND V
OSTROFF S
PELLETT PE
PINNER R
REEF S
REEVES WC
REGNERY R
RICHARDS F
ROGERS M
SCHONBERGER LB
SIMONDS RJ
SIMONE P
SMITH D
SOLOMON S
SPIEGEL R
STEWART J
SWERDLOW D
VERNON S
WARD J
NEAL J
SCHLECH W
WILFERT C
HORSBURGH R
MCGOWAN J
RIMLAND D
GOLDBERGER M
BARR D
TORRES G
STETLER H
GROSS P
ELSADR W
GREAVES W
BARTLETT J
CHAISON R
FEINBERG J
QUINN T
HORMAN J
MACDONALD K
WILSON M
AVANDANO A
BAKER AC
KALICA A
KOVACS J
POLIS M
SCHNITTMAN S
NELSON C
PHAIR J
BENSON C
WOOD B
HUGHES W
LUFT B
HYSLOP N
WHITLEY R
AMPEL N
DREW WL
KOEHLER J
WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - AN OVERVIEW/, Clinical infectious diseases, 21, 1995, pp. 12-31
Authors:
KAPLAN JE
MASUR H
HOLMES KK
LANIER D
SCHRAM N
COOPER E
FREEDBERG KA
MAYER K
BLINKHORN R
ELLNER J
ANGULO F
BERKELMAN R
BREIMAN R
BRYAN R
BUEHLER J
CALDWELL B
CASTRO K
CHILDS JE
CHU S
CIESIELSKI C
DROTMAN DP
EDLIN B
ELLERBROCK T
FLEMING P
GEITER L
HAJJEH R
HANSON D
HOLMBERG S
HUGHES J
JAFFE H
JONES J
JURANEK D
KELLER D
MARTONE W
MCNEIL MM
MILLER B
NAVIN T
NESLUND V
OSTROFF S
PELLETT PE
PINNER R
REEF S
REEVES WC
REGNERY R
RICHARDS F
ROGERS M
SCHONBERGER LB
SIMONDS RJ
SIMONE P
SMITH D
SOLOMON S
SPIEGEL R
STEWART J
SWERDLOW D
VERNON S
WARD J
NEAL J
SCHLECH W
WILFERT C
HORSBURGH R
MCGOWAN J
RIMLAND D
GOLDBERGER M
TRAPNELL CB
BARR D
TORRES G
STETLER H
GROSS P
ELSADR W
COTTON D
GREAVES W
BARTLETT J
CHAISSON R
FEINBERG J
QUINN T
HORMAN J
MACDONALD K
WILSON M
SPERLING R
AVANDANO A
BAKER AC
KALICA A
KOVACS J
POLIS M
SCHNITTMAN S
NELSON C
PHAIR J
BENSON C
WOOD B
HUGHES W
LUFT B
HYSLOP N
WHITLEY R
AMPEL N
DREW WL
KOEHLER J
WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/, Clinical infectious diseases, 21, 1995, pp. 32-43
Authors:
PHAIR JP
GROSS PA
KAPLAN JE
MASUR H
HOLMES KK
WILFERT CM
Citation: Jp. Phair et al., QUALITY STANDARDS FOR PREVENTING OPPORTUNISTIC INFECTIONS RELATED TO HUMAN-IMMUNODEFICIENCY-VIRUS AND THEIR IMPLEMENTATION, Clinical infectious diseases, 21, 1995, pp. 125-125
Authors:
GROSS PA
PHAIR JP
KAPLAN JE
HOLMES KK
MASUR H
Citation: Pa. Gross et al., QUALITY STANDARD FOR THE ENUMERATION OF CD4(-IMMUNODEFICIENCY-VIRUS()LYMPHOCYTES IN ADULTS AND ADOLESCENTS INFECTED WITH HUMAN), Clinical infectious diseases, 21, 1995, pp. 126-127
Authors:
PHAIR JP
MASUR H
GROSS PA
HOLMES KK
KAPLAN JE
Citation: Jp. Phair et al., QUALITY STANDARD FOR THE PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN ADULTS AND ADOLESCENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21, 1995, pp. 128-129
Authors:
PHAIR JP
GROSS PA
KAPLAN JE
MASUR H
HOLMES KK
WILFERT CM
MARTONE WJ
CASTRO KG
Citation: Jp. Phair et al., QUALITY STANDARD FOR THE IDENTIFICATION AND TREATMENT OF PERSONS COINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS AND MYCOBACTERIUM-TUBERCULOSIS, Clinical infectious diseases, 21, 1995, pp. 130-131
Authors:
WILFERT CM
MASUR H
GROSS PA
KAPLAN JE
HOLMES KK
PHAIR JP
SIMONDS RJ
Citation: Cm. Wilfert et al., QUALITY STANDARD FOR THE PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN INFANTS AND CHILDREN BORN TO WOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21, 1995, pp. 132-133
Authors:
WILFERT CM
GROSS PA
KAPLAN JE
HOLMES KK
MASUR H
PHAIR JP
SIMONDS RJ
Citation: Cm. Wilfert et al., QUALITY STANDARD FOR THE ENUMERATION OF CD4(-IMMUNODEFICIENCY-VIRUS()LYMPHOCYTES IN INFANTS AND CHILDREN EXPOSED TO OR INFECTED WITH HUMAN), Clinical infectious diseases, 21, 1995, pp. 134-135
Authors:
WILFERT CM
KAPLAN JE
GROSS PA
MASUR H
HOLMES KK
PHAIR JP
Citation: Cm. Wilfert et al., QUALITY STANDARD FOR THE IMMUNIZATION OF INFANTS AND CHILDREN BORN TOWOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21, 1995, pp. 136-137
Authors:
GROSS PA
KAPLAN JE
PHAIR JP
MASUR H
WILFERT CM
HOLMES KK
Citation: Pa. Gross et al., INDICATORS FOR ASSESSMENT OF COMPLIANCE WITH QUALITY STANDARDS FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21, 1995, pp. 138-141
Citation: Km. Spooner et al., ANTIRETROVIRAL THERAPY - REFERENCE GUIDE TO MAJOR CLINICAL-TRIALS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 20(5), 1995, pp. 1145-1151
Authors:
WALKER RE
CARTER CS
MUUL L
NATARAJAN V
HERPIN BR
LEITMAN SF
KLEIN HG
FALLOON J
DAVEY RT
KOVACS JA
POLIS MA
MASUR H
BLAESE RM
LANE HC
Citation: Re. Walker et al., SURVIVAL AND DISTRIBUTION OF GENETICALLY-MODIFIED CELLS IN IDENTICAL-TWINS DISCORDANT FOR HIV-1 INFECTION, AIDS research and human retroviruses, 11, 1995, pp. 166-166
Authors:
HOLSHOUSER BA
KOMU M
MOLLER HE
ZIJLMANS T
KOLEM H
HINSHAW DB
SONNINEN P
VERMATHEN P
HEERSCHAP A
MASUR H
RINNE UK
DEKOSTER A
TOSK JM
Citation: Ba. Holshouser et al., LOCALIZED PROTON NMR-SPECTROSCOPY IN THE STRIATUM OF PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE - A MULTICENTER PILOT-STUDY, Magnetic resonance in medicine, 33(5), 1995, pp. 589-594